Purple Biotech Receives Nasdaq Minimum Bid Price Notification

Purple Biotech Ltd. (NASDAQ/TASE: PPBT) announced on October 20, 2025, that it received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement. The company's American Depositary Shares (ADSs) have been trading below the required $1.00 per share for 30 consecutive trading days. Purple Biotech has 180 days, until April 14, 2026, to regain compliance. If the ADSs close at or above $1.00 for ten consecutive business days during this period, compliance will be regained. The notification does not immediately affect the company's Nasdaq listing or the trading of its ADSs. Purple Biotech may consider options to address the deficiency, including potentially changing the ratio between its ADSs and ordinary shares. The company remains listed on the Tel Aviv Stock Exchange.